Skip to main content
Log in

Malignant pheochromocytoma: Clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Twenty patients, 16 males and 4 females, aged 11–76 yr, were treated for a metastatic pheochromocytoma at our institution between 1985 and 1990. A neurofibromatosis was associated in 4. Thirteen patients had a unilateral adrenal tumor, 3 had an extraadrenal retroperitoneal tumor, 2 had a bilateral adrenal pheochromocytoma, one had a unilateral tumor with a contralateral medullary hyperplasia and one an adrenal and an extraadrenal pheochromocytoma. Metastases occurred in all patients, at presentation in 11,10 to 30 months later in 7, and 9 and 28 yr later, respectively in two. Histology did not afford conclusive evidence for malignancy. Catecholamine hyperproduction was present in all, predominantly affecting norepinephrine. Neuron Specific Enolase level was elevated in 11, Neuropeptide Y level in 9 and procalcitonin level in 11/18. High dopamine, methoxytyramine and homovanilic acid excretion levels seemed to correlate with large tumors or terminal stage. MIBG uptake was found in 16 after a diagnostic dose and in 1 only after a therapeutic dose. Surgery was performed on primary tumor in 18 and on distant métastase in 10. lodine-131 MIBG therapy was performed in 11, among whom 9 were évaluable. Cumulative activity ranged from 100 to 711 mCi, in 1 to 6 courses. Symptomatic improvement occurred in 5 patients, stabilization was observed in 3 and tumor partial response in two, which lasted for 28 and 9 months, respectively terminating in a rapidly progressing disease with bone marrow involvement. Moderate myelosuppression occurred in 4 patients. Chemotherapy gave no response in 7 evaluable patients. Fourteen patients died with a median survival of 16 months from diagnosis of metastases (range 3–60). Response to therapy was poor and warrants further cooperative trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Mahoney E.M., Harrison J.H. Malignant pheochromocytoma: clinical course and treatment. J. Urol. 118: 225, 1977.

    PubMed  CAS  Google Scholar 

  2. Lewi H.J.E., Reid R., Mucci B., Davidson J.K., Kyle K.F., Mc Pherson S.G., Semple P., Kaye S. Malignant pheochromocytoma. Br. J. Urol. 57: 394, 1985.

    Article  PubMed  CAS  Google Scholar 

  3. Van Herdeen J.A., Sheps S.G., Hamberger B., Sheedy P.F., Poston J.G., Remine W.H. Pheochromocytoma: current status and changing trends. Surgery 91: 367, 1982.

    Google Scholar 

  4. Plouin P.F., Degoulet P., Tugaye A., Ducrocq M.B., Menard J. Le dépistage du phéochromocytome chez quels hypertendus? Etude sémiologique chez 2585 hypertendus dont 11 ayant un phéochromocytome. Nouv. Press. Méd. 10: 869, 1981.

    CAS  Google Scholar 

  5. Manger W.M., Gifford R.W. Hypertension secondary to pheochromocytoma. Bull. N.Y. Acad. Med. 58: 139, 1982.

    PubMed Central  PubMed  CAS  Google Scholar 

  6. Scott W.H., Reynolds V., Green N., Page D., Oates J.A., Robertson D., Roberts S. Clinical experience with malignant phaeochromocytoma. Surg. Gyn. Obs. 154: 801, 1982.

    Google Scholar 

  7. Shapiro B., Sisson J.C., Lloyd R., Nakajo M., Satterlee W., Beierwaltes W.H. Malignant phaeochromocytoma: clinical, biochemical and scintigraphic characterization. Clin. Endocrinol. (Oxf.) 20: 189, 1984.

    Article  CAS  Google Scholar 

  8. Samaan N.A., Hickey R.C., Shutts P.E. Diagnosis, localization and management of pheochromocytoma. Cancer 62: 2451, 1988.

    Article  PubMed  CAS  Google Scholar 

  9. Beierwaltes W.H. Update on basic research and clinical experience with metaiodobenzylguanidine. Med. Ped. Oncol. 15: 163, 1987.

    Article  CAS  Google Scholar 

  10. Shapiro B., Copp J.E., Sisson J.C., Eyre P.L., Wallis J., Beierwaltes W.H. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J. Nucl. Med. 26: 576, 1985.

    PubMed  CAS  Google Scholar 

  11. Ackery D.M., Tippett P.A., Condon B.R., Sutton H.E., Wyeth P. New approach to the localisation of phaeochromocytoma: imaging with iodine-131-metaiodobenzyl-guanidine. Br. Med. J. 288: 1587, 1984.

    Article  CAS  Google Scholar 

  12. DeLellis R.A. The adrenal glands. In: Sternberg S.S. (Ed), Diagnostic Surgical Pathology. Raven Press, New York, 1988, p. 445.

    Google Scholar 

  13. Plouin P.F., Duclos J.M., Menard J., Comoy E., Bohuon C., Alexandre J.M. Biochemical tests for diagnosis of phaeochromocytoma: urinary versus plasma determinations. Br. Med. J. 282: 853, 1981.

    Article  CAS  Google Scholar 

  14. Grouzmann E., Comoy E., Bohuon C. Plasma neuropeptide Y concentrations in patients with neuroendocrine tumors. J. Clin. Endocrinol. Metab. 64: 808, 1989.

    Article  Google Scholar 

  15. Motte P., Vauzelle P., Gardet P., Ghillani P., Caillou B., Parmentier C., Bohuon C., Bellet D. Construction and clinical validation of a sensitive and specific assay for serum mature calcitonin using monoclonal anti-peptide antibodies. Clin. Chim. Acta 174: 35, 1988.

    Article  PubMed  CAS  Google Scholar 

  16. Ghillani P.P., Motte P., Troalen F., Jullienne A., Gardet P., Le Chevalier T., Rougier P., Schlumberger M., Bohuon C., Bellet D. Identification and measurement of calcitonin precursors in serum of patients with malignant disease. Cancer Res. 49: 6845, 1989.

    PubMed  CAS  Google Scholar 

  17. Tapia F.J., Polak J.M., Barbosa A.J.A., Bloom S.R., Marangos P.J., Dermody C., Pearse A.G.E. Neuron-specific enolase is produced by neuroen docrine tumors. Lancet 1: 808, 1981.

    Article  PubMed  CAS  Google Scholar 

  18. Schlumberger M., Charbord P., Fragu P., Gardet P., Lumbroso J., Parmentier C., Tubiana M. Relationship between TSH stimulation and radioio-dine uptake in lung metastases of differentiated thy roid carcinoma. J. Clin. Endocrinol. Metab. 57: 148, 1983.

    Article  PubMed  CAS  Google Scholar 

  19. Krempf H., Lumbroso J., Mornex R., Brendel A.J., Wemeau J.L., Delisle HJ., Aubert B., Carpentier P., Fleury-Goyon M.C., Gibold C., Guyot M., Lanheche B., Marchandise X., Schlumberger M., Charbonnel B., Chatal J.F. Use of 131l m-lodobenzylguanidine (131I-MIBG) in the treatment of malignant pheochromocytoma. J. Clin. Endocrinol. Metab. 72: 445, 1991.

    Article  Google Scholar 

  20. Riccardi V.M. Von Recklinghausen neurofibromatosis. N. Engl. J. Med. 305: 1617, 1981.

    Article  PubMed  CAS  Google Scholar 

  21. Horton W.A., Wong V., Eldrich R. Von Hippel-Lindau disease. Arch. Intern. Med. 136: 769, 1976.

    Article  PubMed  CAS  Google Scholar 

  22. Allen J.M., Yeats J.C., Causon R., Brown M.J., Bloom S.R. Neuropeptide Y and its flanking peptide in human endocrine tumors and plasma. J. Clin. Endocrinol. Metab. 64: 1199, 1987.

    Article  PubMed  CAS  Google Scholar 

  23. Grouzmann E., Gicquel C., Plouin P.F., Schlumberger M., Comoy E., Bohuon C. Neuropeptide Y and Neuron Specific Enolase levels in benign and malignant pheochromocytomas. Cancer 66: 1833, 1990.

    Article  PubMed  CAS  Google Scholar 

  24. Oishi S., Tatsuo S. Elevated serum neuron-specific enolase in patients with malignant phaeochromocytoma. Cancer 61: 1167, 1988.

    Article  PubMed  CAS  Google Scholar 

  25. Schlumberger M., Tubiana M., De Vathaire F., C., Gardet P., Travagli J.P., Fragu P., Lumbroso J., Caillou B., Parmentier C. Long-term results of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 63: 960, 1986.

    Article  PubMed  CAS  Google Scholar 

  26. Sisson J.C., Shapiro B., Beierwaltes W.H., Glonniak J.V., Nakajo M., Mangner T.J., Carey J.E., Swanson DP., Copp J.E., Satterlee W.G., Wieland D.M. Radiopharmaceutical treatment of malignant pheochromocytoma. J. Nucl. Med. 24: 197, 1984.

    Google Scholar 

  27. Averbuch S.D., Steakley CS., Young R.C., Gelmann E.P., Goldstein D.S., Stull R., Keiser H.R. Malignant pheochromocytoma: effective treatment with a combination of Cyclophosphamide, Vincristine and Dacarbazine. Ann. Intern. Med. 109: 267, 1988.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schlumberger, M., Gicquel, C., Lumbroso, J. et al. Malignant pheochromocytoma: Clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases. J Endocrinol Invest 15, 631–642 (1992). https://doi.org/10.1007/BF03345807

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345807

Key-words

Navigation